Concomitant primary myelofibrosis and chronic myelogenous leukemia treated with ruxolitinib and TKIs

Moe Kadono

Presentation information

Poster Session

Sat. Oct, 13

Poster Session 2-12 MPN: Case reports

Sat. Oct 13, 2018 5:30 PM - 6:10 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Chair: Yuka Sugimoto (Department of Hematology and Oncology, Mie University Hospital)

[PS2-12-1] Concomitant primary myelofibrosis and chronic myelogenous leukemia treated with ruxolitinib and TKIs

Moe Kadono¹, Hisayuki Yao¹, Shoso Munemasa¹, Takeshi Shimomura¹, Seiko Yamada², Toshinori Kondo², Hideho Wada² (1.Department of Hematology, National Hospital Organization, Hiroshima-Nishi Medical Center, 2.Division of Hematology, Department of Medicine, Kawasaki Medical School)

Abstract password authentication.
Password is written on a program and abstract book.